BRIEF-Theravance Biopharma highlights positive results from phase 3 fulfil study of closed triple announced by Glaxosmithkline, Innoviva
June 20, 2016 at 20:48 PM EDT
* Highlights positive top-line results from pivotal phase 3 fulfil study of closed triple announced by Glaxosmithkline, Innoviva